Related Experiment Video
Updated: Sep 3, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Panaxytriol Inhibits Lipopolysaccharide-Induced Microglia Activation in Brain Inflammation in Vivo
Genki Hiramatsu1, Kosuke Matsuda1, Daisuke Uta1
1Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.
Abstract:
Brain inflammation is a pathological characteristic of neurodegenerative diseases. In this condition, excessively activated microglia elevate proinflammatory mediator levels. We previously reported that panaxytriol inhibited lipopolysaccharide (LPS)-induced microglia activation in vitro. However, the effects of panaxytriol on microglia activation in vivo require confirmation. In the present study, we found that panaxytriol suppressed both microglia and astrocyte activation by injected LPS intracerebrally to mice with LPS-induced brain inflammation. Panaxytriol was more effective on microglia than astrocytes. Moreover, panaxytriol tended to reduce LPS-induced spontaneous motor activity dysfunction. These results suggested that panaxytriol could improve brain health by suppressing microglia activation in neurodegenerative diseases.
Insights
Panaxytriol suppresses brain inflammation by reducing microglia and astrocyte activation in mice with neuroinflammation. This compound shows potential for improving brain health in neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Brain inflammation, characterized by activated microglia, is central to neurodegenerative diseases.
- Previous in vitro studies indicated panaxytriol inhibits lipopolysaccharide (LPS)-induced microglia activation.
- The in vivo efficacy of panaxytriol on neuroinflammation requires further investigation.
Purpose of the Study:
- To confirm the in vivo effects of panaxytriol on microglia and astrocyte activation in a mouse model of brain inflammation.
- To evaluate the impact of panaxytriol on LPS-induced motor dysfunction.
Main Methods:
- Intracerebral injection of lipopolysaccharide (LPS) to induce brain inflammation in mice.
- Administration of panaxytriol to assess its effects on microglia and astrocyte activation.
- Assessment of spontaneous motor activity to evaluate functional recovery.
Main Results:
- Panaxytriol significantly suppressed both microglia and astrocyte activation in LPS-induced brain inflammation.
- The compound demonstrated a more pronounced effect on microglia compared to astrocytes.
- Panaxytriol tended to ameliorate LPS-induced spontaneous motor activity dysfunction.
Conclusions:
- Panaxytriol effectively suppresses neuroinflammation by inhibiting microglia and astrocyte activation in vivo.
- These findings suggest panaxytriol holds therapeutic potential for neurodegenerative diseases characterized by brain inflammation.
- Further research into panaxytriol's mechanisms and clinical applications is warranted.
